These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37392953)
61. Lamb's tripe extract and vitamin B Wu SR; Liu J; Zhang LF; Wang N; Zhang LY; Wu Q; Liu JY; Shi YQ World J Clin Cases; 2021 Dec; 9(34):10472-10483. PubMed ID: 35004979 [TBL] [Abstract][Full Text] [Related]
62. Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia. Wu MS; Shun CT; Lee WC; Chen CJ; Wang HP; Lee WJ; Lin JT Br J Cancer; 1998 Jul; 78(1):125-8. PubMed ID: 9662262 [TBL] [Abstract][Full Text] [Related]
63. Gastric Antral Mucosal Changes in Children With Intestinal Metaplasia. Li G; Kelly DR; Mroczek-Musulman E; Wang K; Council L; Zhao L Pediatr Dev Pathol; 2022; 25(5):511-517. PubMed ID: 35510382 [No Abstract] [Full Text] [Related]
64. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073 [TBL] [Abstract][Full Text] [Related]
65. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer. Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576 [TBL] [Abstract][Full Text] [Related]
66. Distribution of intestinal metaplasia as a predictor of gastric cancer development. Shichijo S; Hirata Y; Sakitani K; Yamamoto S; Serizawa T; Niikura R; Watabe H; Yoshida S; Yamada A; Yamaji Y; Ushiku T; Fukayama M; Koike K J Gastroenterol Hepatol; 2015 Aug; 30(8):1260-4. PubMed ID: 25777777 [TBL] [Abstract][Full Text] [Related]
67. Accuracy of artificial intelligence-assisted endoscopy in the diagnosis of gastric intestinal metaplasia: A systematic review and meta-analysis. Li N; Yang J; Li X; Shi Y; Wang K PLoS One; 2024; 19(5):e0303421. PubMed ID: 38743709 [TBL] [Abstract][Full Text] [Related]
68. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Cho SJ; Choi IJ; Kook MC; Nam BH; Kim CG; Lee JY; Ryu KW; Kim YW Aliment Pharmacol Ther; 2013 Nov; 38(10):1292-302. PubMed ID: 24134499 [TBL] [Abstract][Full Text] [Related]
69. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. Tava F; Luinetti O; Ghigna MR; Alvisi C; Perego M; Trespi E; Klersy C; Fratti C; Fiocca R; Solcia E Hum Pathol; 2006 Nov; 37(11):1489-97. PubMed ID: 16949645 [TBL] [Abstract][Full Text] [Related]
70. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer. Tsai YC; Hsiao WH; Yang HB; Cheng HC; Chang WL; Lu CC; Sheu BS Aliment Pharmacol Ther; 2013 May; 37(10):969-78. PubMed ID: 23550594 [TBL] [Abstract][Full Text] [Related]
71. Subtypes of intestinal metaplasia and their relationship to Helicobacter pylori. Evrensel T; Manavoğlu O; Ozyardimci C; Orhan B; Gülten M; Nak SG; Yerci O J Environ Pathol Toxicol Oncol; 1996; 15(2-4):221-4. PubMed ID: 9216810 [TBL] [Abstract][Full Text] [Related]
72. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia. Koulis A; Di Costanzo N; Mitchell C; Lade S; Goode D; Busuttil RA; Boussioutas A BMC Gastroenterol; 2022 Apr; 22(1):197. PubMed ID: 35448971 [TBL] [Abstract][Full Text] [Related]
73. Role of endoscopy in suspicion of atrophic gastritis with and without intestinal metaplasia in comparison to histopathology. Ibrahim H; El-Deen AS; Kasemy ZA; Saad M; Sakr AA Acta Gastroenterol Belg; 2021; 84(1):9-17. PubMed ID: 33639688 [TBL] [Abstract][Full Text] [Related]
74. Is intestinal metaplasia of the stomach reversible? Walker MM Gut; 2003 Jan; 52(1):1-4. PubMed ID: 12477745 [TBL] [Abstract][Full Text] [Related]
75. Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the West? Marcos P; Brito-Gonçalves G; Libânio D; Pita I; Castro R; Sá I; Dinis-Ribeiro M; Pimentel-Nunes P Gut; 2020 Oct; 69(10):1762-1768. PubMed ID: 32051208 [TBL] [Abstract][Full Text] [Related]
76. Gastric intestinal metaplasia assessment between linked color imaging based on endoscopy and pathology. Zhang G; Zheng J; Zheng L; Yu S; Jiang C; Lin W; Li D; Qu L; Wang W Scand J Gastroenterol; 2021 Jan; 56(1):103-110. PubMed ID: 33232631 [TBL] [Abstract][Full Text] [Related]
78. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655 [TBL] [Abstract][Full Text] [Related]
79. Methylene blue chromoendoscopy is more useful in detection of intestinal metaplasia in the stomach than mucosal pit pattern or vessel evaluation and predicts advanced Operative Link on Gastric Intestinal Metaplasia stages. Wasielica-Berger J; Rogalski P; Pryczynicz A; Swidnicka-Siergiejko A; Dabrowski A Clin Endosc; 2023 Mar; 56(2):203-213. PubMed ID: 36890637 [TBL] [Abstract][Full Text] [Related]
80. Convolutional Neural Network Model for Intestinal Metaplasia Recognition in Gastric Corpus Using Endoscopic Image Patches. Ligato I; De Magistris G; Dilaghi E; Cozza G; Ciardiello A; Panzuto F; Giagu S; Annibale B; Napoli C; Esposito G Diagnostics (Basel); 2024 Jun; 14(13):. PubMed ID: 39001267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]